Prevent It 2.0/GPP -iCBT to Reduce the Risk of Committing Child Sexual Abuse
Status
Conditions
Treatments
Details and patient eligibility
About
Child sexual abuse is a large-scale global problem, and with the internet and communication technologies enabling new ways to sexually abuse children, the problem is drastically increasing.
Prevent It is a free, anonymous, internet-delivered, therapist assisted, cognitive behavioral therapy (CBT) intervention for individuals concerned about their sexual urges or behaviors involving children. The treatment program is based on many years of clinical experience from working with this patient group, results from several previous research projects.
Using the scientifically rigorous design of a randomized controlled trial with waitlist control, we want to evaluate Prevent It 2.0 - an updated cognitive behavioral therapy treatment for individuals who are concerned about their sexual urges regarding children.
The study design is an academically initiated randomized controlled clinical trial where Prevent It 2.0 is compared with waitlist control. Participants in the waitlist control will wait thirteen weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing problematic sexual behavior.
Recruitment will be carried out through multiple channels, and takes place on both "Darknet" and "Clearnet". All contact with participants, the treatment, evaluations, and termination of the contact, is conducted via the online treatment platform Iterapi, designed specifically for clinical trials of Internet-mediated CBT.
The treatment contains nine modules over thirteen weeks and the content of the therapy is classic CBT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- concern about sexual urges regarding children
- Informed consent to participate
Exclusion criteria
- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse)
- Participants that are judged to have a limited understanding of the languages that the treatment is delivered in (English)
- Lack serious intention to participate (assessed by the researcher/therapist during the intake interview, which lasts approximately one hour)
Trial design
Primary purpose
Allocation
Interventional model
Masking
203 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Christoffer Rahm, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal